Published in Clin Cancer Res on July 02, 2012
Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer (2015) 0.96
Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients. Clin Cancer Res (2015) 0.86
High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time. PLoS One (2013) 0.86
In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins. Brain Behav Immun (2013) 0.86
Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids. Psychoneuroendocrinology (2014) 0.83
PGE2 suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity. Brain Behav Immun (2012) 0.80
Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition. Brain Behav Immun (2016) 0.78
Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects. Int J Cancer (2015) 0.78
Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer. World J Gastroenterol (2017) 0.75
Surgery for Cancer: A Trigger for Metastases. Cancer Res (2017) 0.75
Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer. Breast Cancer Res Treat (2017) 0.75
Perioperative COX-2 and β-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin Cancer Res (2017) 0.75
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (2011) 15.79
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Regulation of immune responses by prostaglandin E2. J Immunol (2012) 3.93
Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res (2006) 3.58
Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol (2011) 2.99
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol (2011) 2.90
Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget (2010) 2.64
Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci (2002) 2.51
Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res (2006) 2.37
Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology (2006) 2.36
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res (2006) 2.32
Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res (2004) 2.24
Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res (2001) 2.08
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest (2010) 2.04
M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. J Immunol (2011) 2.02
Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res (2011) 1.84
Stimulation of tumour growth by wound-derived growth factors. Br J Cancer (1999) 1.80
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun (2008) 1.71
Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol (2003) 1.69
Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg (2000) 1.59
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58
Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun (2005) 1.55
β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev (2011) 1.55
In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol (1998) 1.52
Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res (2004) 1.51
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg (2010) 1.46
Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol (2008) 1.44
Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett (2010) 1.42
Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol (1995) 1.35
Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg (2011) 1.33
The net immunologic advantage of laparoscopic surgery. Surg Endosc (2004) 1.31
Functions of skin-resident γδ T cells. Cell Mol Life Sci (2011) 1.27
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol (2010) 1.26
Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells (2009) 1.22
Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation (2000) 1.21
Tumor-vascular interactions and tumor dormancy. APMIS (2008) 1.16
The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg (2009) 1.15
Endocrine and metabolic changes during surgery: anaesthetic implications. Br J Anaesth (1981) 1.15
Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells. Immunology (2010) 1.13
Killer dendritic cells and their potential for cancer immunotherapy. Cancer Immunol Immunother (2009) 1.10
Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann Surg Oncol (2003) 1.10
Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity. Arch Surg (1991) 1.10
Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem J (1990) 1.04
Beta-adrenergic receptors in human leukocyte subpopulations. Eur J Clin Invest (1992) 1.04
The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling. Oncol Rep (2010) 1.04
Continuous stress disrupts immunostimulatory effects of IL-12. Brain Behav Immun (2011) 0.99
Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol Behav (1996) 0.98
Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3. Cancer Res (2011) 0.97
Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity. J Biol Chem (1997) 0.97
Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS One (2011) 0.96
Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol (1995) 0.96
Adaptive immunity in mice lacking the beta(2)-adrenergic receptor. Brain Behav Immun (2003) 0.95
Laparoscopic versus open colorectal resection for cancer: a meta-analysis of results of randomized controlled trials on recurrence. Eur J Surg Oncol (2007) 0.94
The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells. J Immunother (2010) 0.94
Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain Behav Immun (2007) 0.94
A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer. Anticancer Res (2009) 0.94
Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells. J Clin Invest (1985) 0.94
Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells. Brain Behav Immun (2010) 0.94
Immune perturbations in patients along the perioperative period: alterations in cell surface markers and leukocyte subtypes before and after surgery. Brain Behav Immun (2009) 0.92
Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer (2004) 0.92
Modulation of human NK cells by interferon and prostaglandin E2. Mol Immunol (1982) 0.91
Effects of stress on alveolar macrophages: a role for the sympathetic nervous system. Am J Respir Cell Mol Biol (1998) 0.91
Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder. Mol Cancer Ther (2010) 0.91
Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer. Breast Cancer Res Treat (2010) 0.91
Beta-adrenergic receptors in cancer: therapeutic implications. Oncol Res (2010) 0.89
Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status. Breast Cancer Res Treat (2000) 0.89
CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination. J Immunother (2009) 0.88
A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia. Ann Surg Oncol (2009) 0.87
On the cell biology of pit cells, the liver-specific NK cells. World J Gastroenterol (2000) 0.86
Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy. Cancer J (2011) 0.86
Pitfalls on the roadmap to gammadelta T cell-based cancer immunotherapies. Immunol Lett (2009) 0.85
The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother (1996) 0.85
Reduction of cell proliferation and potentiation of Fas-induced apoptosis by the selective kappa-opioid receptor agonist U50 488 in the multiple myeloma LP-1 cells. J Neuroimmunol (2010) 0.84
An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int Arch Allergy Appl Immunol (1989) 0.84
Neuroendocrine regulation of skin dendritic cells. Ann N Y Acad Sci (2006) 0.83
Additive effects of epinephrine and corticotropin-releasing factor (CRF) on adrenocorticotropin release in rat anterior pituitary cells. Biochem Biophys Res Commun (1983) 0.83
Cancer in transplant recipients. Transplant Proc (2000) 0.82
Effects of beta-adrenoceptor-blockade on stress-induced adrenocorticotrophin release in humans. Eur J Appl Physiol Occup Physiol (1998) 0.77
Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology (2008) 3.32
Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum (2002) 1.74
Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol (2003) 1.69
Actual colonic perforation in virtual colonoscopy: report of a case. Dis Colon Rectum (2004) 1.63
Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis. Brain Behav Immun (2006) 1.57
Gracilis muscle interposition for the treatment of rectourethral, rectovaginal, and pouch-vaginal fistulas: results in 53 patients. Ann Surg (2008) 1.56
Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun (2005) 1.55
Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol (2008) 1.44
Perianal Crohn's disease. Isr Med Assoc J (2007) 1.42
Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg (2003) 1.40
Adhesion prevention and reduction: current status and future recommendations of a multinational interdisciplinary consensus conference. Surg Innov (2010) 1.33
Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg (2011) 1.33
Use of the ON-Q pain management system is associated with decreased postoperative analgesic requirement: double blind randomized placebo pilot study. J Am Coll Surg (2006) 1.29
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol (2010) 1.26
Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation (2004) 1.11
Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann Surg Oncol (2003) 1.10
The combined laparoscopic approach for the treatment of incarcerated inguinal hernia. Surg Endosc (2010) 1.10
Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav Immun (2012) 1.04
Low incidence of adhesion-related bowel obstruction after laparoscopic colorectal surgery. J Laparoendosc Adv Surg Tech A (2007) 1.04
Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials (2008) 1.02
European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis (2015) 1.01
Bowel preparation is associated with spillage of bowel contents in colorectal surgery. Dis Colon Rectum (2005) 1.00
Continuous stress disrupts immunostimulatory effects of IL-12. Brain Behav Immun (2011) 0.99
A technique for laparoscopic-assisted colectomy using two ports. JSLS (2004) 0.99
Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS One (2011) 0.96
Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis. Inflamm Bowel Dis (2012) 0.95
The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells. J Immunother (2010) 0.94
Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain Behav Immun (2007) 0.94
Amelioration of operation-induced suppression of marginating pulmonary NK activity using poly IC: a potential approach to reduce postoperative metastasis. Ann Surg Oncol (2006) 0.93
Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells. Cancer Immunol Immunother (2006) 0.93
Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins. Brain Behav Immun (2008) 0.92
Immune perturbations in patients along the perioperative period: alterations in cell surface markers and leukocyte subtypes before and after surgery. Brain Behav Immun (2009) 0.92
Endoscopic ultrasound staging of rectal cancer: diagnostic value before and following chemoradiation. J Gastroenterol Hepatol (2006) 0.92
Laparoscopic resection of gastric Dieulafoy lesion following preoperative tattooing. Isr Med Assoc J (2011) 0.91
CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination. J Immunother (2009) 0.88
The efficacy of a nerve stimulator (CaverMap) to enhance autonomic nerve identification and confirm nerve preservation during total mesorectal excision. Dis Colon Rectum (2004) 0.88
Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses. Cancers (Basel) (2010) 0.88
The marginating-pulmonary immune compartment in mice exhibits increased NK cytotoxicity and unique cellular characteristics. Immunol Res (2014) 0.87
Resilience of the immune system in healthy young students to 30-hour sleep deprivation with psychological stress. Neuroimmunomodulation (2013) 0.86
In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins. Brain Behav Immun (2013) 0.86
Poly I-C induces early embryo loss in f344 rats: a potential role for NK cells. Am J Reprod Immunol (2005) 0.85
Prophylactic IL-12 treatment reduces postoperative metastasis: mediation by increased numbers but not cytotoxicity of NK cells. Breast Cancer Res Treat (2007) 0.85
Synergism between immunostimulation and prevention of surgery-induced immune suppression: an approach to reduce post-operative tumor progression. Brain Behav Immun (2010) 0.84
Physicochemical properties of double-stranded RNA used to discover a reo-like virus from blue crab Callinectes sapidus. Dis Aquat Organ (2010) 0.84
Male--female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement. J Neuroimmunol (2007) 0.83
Focused, minimally invasive radio-guided parathyroidectomy: a feasible and safe option for elderly patients with primary hyperparathyroidism. Isr Med Assoc J (2003) 0.81
The efficacy of a nerve stimulator (Cavermap) to enhance autonomic nerve identification and confirm nerve preservation during total mesorectal excision. Dis Colon Rectum (2005) 0.81
Laparoscopic subtotal gastrectomy for gastric cancer. JSLS (2009) 0.80
Stress and skin leukocyte trafficking as a dual-stage process. Brain Behav Immun (2011) 0.79
A new rectal ultrasonographic method for the staging of rectal cancer. Dis Colon Rectum (2009) 0.79
Impact of surgical extent and sex on the hepatic metastasis of colon cancer. Surg Today (2013) 0.79
CpG-C immunotherapeutic efficacy is jeopardized by ongoing exposure to stress: potential implications for clinical use. Brain Behav Immun (2010) 0.78
Laparoscopic resection of rectal cancer. Isr Med Assoc J (2011) 0.78
Outcome of patients with indeterminate colitis undergoing a double-stapled ileal pouch-anal anastomosis. Dis Colon Rectum (2004) 0.78
Are there specific endosonographic features in Crohn's patients with perianal fistulae? J Crohns Colitis (2012) 0.78
Indomethacin attenuates the immunosuppressive and tumor-promoting effects of surgery. J Pain (2002) 0.77
High NK cell activity in recurrent miscarriage: what are we really measuring? Hum Reprod (2006) 0.77
Fish oil attenuates surgery-induced immunosuppression, limits post-operative metastatic dissemination and increases long-term recurrence-free survival in rodents inoculated with cancer cells. Clin Nutr (2011) 0.77
Long-term results of fibrin glue treatment for cryptogenic perianal fistulas: a multicenter study. Dis Colon Rectum (2011) 0.76
Perioperative polyphenon E, a green tea extract, does not affect the wound complication rate in mice after sham laparotomy yet has an inhibitory effect on wound healing. Surg Innov (2012) 0.76
Differences in number and activity of peripheral natural killer cells in primary versus secondary recurrent miscarriage. Fertil Steril (2003) 0.76
Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats. Int J Colorectal Dis (2010) 0.76
Endosonographic evaluation of perianal fistulas and abscesses: comparison of two instruments and assessment of the role of hydrogen peroxide injection. J Clin Ultrasound (2005) 0.76
ECCO-ESCP Consensus on Surgery for Crohn's Disease. J Crohns Colitis (2017) 0.76
The Combined Blockade of β-Adrenoceptor and COX-2 During the Perioperative Period to Improve Long-term Cancer Outcomes. Int Anesthesiol Clin (2016) 0.75
Perianal Paget's disease. J Cutan Med Surg (2007) 0.75
A phase I study of oral UFT given concomitantly with standard preoperative radiotherapy for rectal cancer. Isr Med Assoc J (2004) 0.75
Hand-assisted laparoscopic colectomy for colovesical fistula associated with diverticular disease. Surg Laparosc Endosc Percutan Tech (2014) 0.75
Preoperative Nutritional Optimization for Crohn's Disease Patients Can Improve Surgical Outcome. Dig Surg (2017) 0.75
Sweet's syndrome in association with ulcerative colitis and dyserythropoietic anemia. Digestion (2007) 0.75
Early experience with laparoscopic lavage in acute complicated diverticulitis. Dig Surg (2015) 0.75
Small bowel obstruction from a dislodged feeding tube. Age Ageing (2004) 0.75
Immunosuppressants and operation in ulcerative colitis. J Am Coll Surg (2002) 0.75
Healing of ileocolic nitinol compression anastomosis: a novel porcine model of subtotal colectomy. Surg Innov (2013) 0.75
[Laparoscopic colon and rectal surgery--after ten years and 350 operations]. Harefuah (2007) 0.75